98%
921
2 minutes
20
Objective: Although seizures are the cardinal feature, epilepsy is associated with other forms of brain dysfunction including impaired cognition, abnormal sleep, and increased risk of developing dementia. We hypothesized that, given the widespread neurologic dysfunction caused by epilepsy, accelerated brain aging would be seen. We measured the sleep-based brain age index (BAI) in a diverse group of patients with epilepsy. The BAI is a machine learning-based biomarker that measures how much the brain activity of a person during overnight sleep deviates from chronological age-based norms.
Methods: This case-control study drew information of age-matched controls without epilepsy from home sleep monitoring volunteers and from non-epilepsy patients with Sleep Lab testing. Patients with epilepsy underwent in-patient monitoring and were classified by epilepsy type and seizure burden. The primary outcomes measured were BAI, processed from electroencephalograms, and epilepsy severity metrics (years with epilepsy, seizure frequency standardized by year, and seizure burden [number of seizures in life]). Subanalyses were conducted on a subset with NIH Toolbox cognitive testing for total, fluid, and crystallized composite cognition.
Results: 138 patients with epilepsy (32 exclusively focal and 106 generalizable [focal seizures with secondary generalization]) underwent in-patient monitoring, and age-matched, non-epilepsy controls were analyzed. The mean BAI was higher in epilepsy patients vs controls and differed by epilepsy type: -0.05 years (controls) versus 5.02 years (all epilepsy, < 0.001), 5.53 years (generalizable, < 0.001), and 3.34 years (focal, = 0.03). Sleep architecture was disrupted in epilepsy, especially in generalizable epilepsy. A higher BAI was positively associated with increased lifetime seizure burden in focal and generalizable epilepsies and associated with lower crystallized cognition. Lifetime seizure burden was inversely correlated with fluid, crystallized, and composite cognition.
Significance: Epilepsy is associated with accelerated brain aging. Higher brain age indices are associated with poorer cognition and more severe epilepsy, specifically generalizability and higher seizure burden. These findings strengthen the use of the sleep-derived, electroencephalography-based BAI as a biomarker for cognitive dysfunction in epilepsy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11634596 | PMC |
http://dx.doi.org/10.3389/fphys.2024.1458592 | DOI Listing |
J Child Neurol
September 2025
Department of Neurology, Nationwide Children's Hospital, Columbus, OH, USA.
This case report describes the use of doxazosin (Cardura) as a treatment for a patient with an autosomal dominant , single-nucleotide R398Q pathogenic variant, which has not previously been described in the literature. The patient has gain-of-function pathogenic genetic variant. Because of the patient's continued seizure burden with the use of traditional antiseizure medications and failed invasive antiseizure interventions, an oocyte cell line with the specific genetic variant was created to test efficacy of various medications.
View Article and Find Full Text PDFEpilepsy affects around 1% of the global population and often requires long-term treatment with antiseizure medications (ASMs). However, the current treatment strategy is based on clinical acumen and trial and error, resulting in only about 50% of patients remaining seizure-free for at least 12 months with first-line ASMs. Valproic acid (VPA) is a commonly prescribed first-line ASM, yet <50% of patients experience inadequate seizure control (ISC) or unacceptable adverse reactions (UARs), necessitating discontinuation.
View Article and Find Full Text PDFEur J Pediatr
September 2025
Child Neuropsychiatry Unit, University-Hospital Policlinico Umberto I, Istituto Di Neuropsichiatria Infantile "G. Bollea", Via Dei Sabelli 108, 00185, Rome, Italy.
Unlabelled: Neonatal status epilepticus (NSE) is associated with poor survival and adverse neurological outcomes. However, current definitions only partially account for the unique pathophysiology of the neonatal brain and the clinical context of acute symptomatic seizures. To address this gap, international efforts are underway to develop a more specific and context-appropriate definition for the neonatal period.
View Article and Find Full Text PDFCell Commun Signal
September 2025
CNR Institute of Biochemistry and Cell Biology, Monterotondo, Rome, 00015, Italy.
Background: Connexin (Cx) hemichannels (HCs) contribute to glioblastoma (GBM) progression by facilitating intercellular communication and releasing pro-tumorigenic molecules, including ATP and glutamate.
Methods: The efficacy of abEC1.1, a monoclonal antibody that inhibits Cx26, Cx30, and Cx32 HCs, was assessed in vitro by measuring invasion capability, dye and Ca uptake, glutamate and ATP release in patient-derived GBM cultures or organoids.
Epilepsy Behav
September 2025
Professor of Cultural and Social Anthropology, Dept. of Literature, Art and History, Chieti-Pescara University, Via dei Vestini 31, Chieti, Italy. Electronic address:
To live with epilepsy is to inhabit a space of perpetual uncertainty-between seizures, between wellness and risk, between life and the threat of sudden death. This editorial reflects on two recent contributions to Epilepsy & Behaviour addressing SUDEP risk communication and the redefinition of healing in epilepsy. Drawing on anthropological and phenomenological perspectives, the article explores how epilepsy disrupts categories of time, agency, and identity, and how biomedical approaches often fail to grasp the moral and relational dimensions of such disruption.
View Article and Find Full Text PDF